Theophylline-binding RNA aptamer (Theo-aptamer) (Theo-aptamer)

The theophylline-binding RNA aptamer is a synthetic RNA sequence engineered to bind the small molecule theophylline with high affinity and specificity. Discovered via SELEX (Systematic Evolution of Ligands by Exponential Enrichment), it exhibits a 10,000-fold higher affinity for theophylline compared to the closely related methylxanthine, caffeine (Jenison et al., 1994). In synthetic biology, this aptamer is frequently integrated into the 5' or 3' untranslated regions of mRNA to function as a riboswitch, allowing for the precise control of gene expression in response to exogenous theophylline (Wieland & Hartig, 2008). While not a naturally occurring human protein, it serves as a critical component in the development of "safety switches" for cell and gene therapies, enabling clinicians to modulate therapeutic activity (Zimmermann et al., 2000). The binding event typically induces a structural rearrangement that either masks or exposes functional RNA elements like ribosome binding sites or ribozymes (Lynch & Gallivan, 2009). Its robust performance across various organisms, from bacteria to mammalian cells, makes it a foundational tool for biosensing and metabolic engineering. The aptamer's structure consists of a core binding pocket formed by a 15-nucleotide internal loop that stabilizes upon ligand interaction. This molecular recognition is highly sensitive to the presence of a single methyl group, which accounts for its discrimination against caffeine.

Other names

Theophylline aptamerT-aptamerTheophylline-responsive riboswitchTheophylline-binding RNA

The aptamer functions as an allosteric RNA switch; upon binding theophylline, it undergoes a conformational change that regulates downstream processes such as translation initiation, mRNA stability, or alternative splicing (Lynch & Gallivan, 2009).